HealthEquity Share Holder Equity 2014-2024 | HQY

HealthEquity share holder equity from 2014 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • HealthEquity share holder equity for the quarter ending October 31, 2024 was $2.125B, a 6.88% increase year-over-year.
  • HealthEquity share holder equity for 2024 was $2.035B, a 7.35% increase from 2023.
  • HealthEquity share holder equity for 2023 was $1.896B, a 2.32% increase from 2022.
  • HealthEquity share holder equity for 2022 was $1.853B, a 34.37% increase from 2021.
HealthEquity Annual Share Holder Equity
(Millions of US $)
2024 $2,035
2023 $1,896
2022 $1,853
2021 $1,379
2020 $1,030
2019 $477
2018 $346
2017 $262
2016 $203
2015 $144
2014 $-13
2013 $-6
HealthEquity Quarterly Share Holder Equity
(Millions of US $)
2024-10-31 $2,125
2024-07-31 $2,157
2024-04-30 $2,098
2024-01-31 $2,035
2023-10-31 $1,988
2023-07-31 $1,950
2023-04-30 $1,919
2023-01-31 $1,896
2022-10-31 $1,883
2022-07-31 $1,865
2022-04-30 $1,855
2022-01-31 $1,853
2021-10-31 $1,872
2021-07-31 $1,863
2021-04-30 $1,848
2021-01-31 $1,379
2020-10-31 $1,355
2020-07-31 $1,340
2020-04-30 $1,041
2020-01-31 $1,030
2019-10-31 $1,018
2019-07-31 $1,017
2019-04-30 $529
2019-01-31 $477
2018-10-31 $457
2018-07-31 $433
2018-04-30 $397
2018-01-31 $346
2017-10-31 $334
2017-07-31 $316
2017-04-30 $291
2017-01-31 $262
2016-10-31 $253
2016-07-31 $239
2016-04-30 $223
2016-01-31 $203
2015-10-31 $198
2015-07-31 $191
2015-04-30 $155
2015-01-31 $144
2014-10-31 $141
2014-07-31 $11
2014-04-30 $0
2014-01-31
2013-10-31 $0
2013-07-31 $0
2013-01-31 $-6
Sector Industry Market Cap Revenue
Medical Medical Services $8.876B $1.000B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $89.358B 11.09
Cencora (COR) United States $46.783B 17.59
DiDi Global (DIDIY) China $22.844B 0.00
Natera (NTRA) United States $20.907B 0.00
ICON (ICLR) Ireland $16.343B 14.56
Avantor (AVTR) United States $15.048B 22.56
Revvity (RVTY) United States $14.408B 25.03
BioMerieux (BMXMF) France $13.788B 0.00
Viatris (VTRS) United States $13.488B 4.15
Solventum (SOLV) United States $12.699B 0.00
CochLear (CHEOY) Australia $12.341B 0.00
Medpace Holdings (MEDP) United States $10.485B 29.54
Doximity (DOCS) United States $10.029B 59.03
EUROFINS SCIENT (ERFSF) Luxembourg $9.551B 0.00
Charles River Laboratories (CRL) United States $8.361B 16.16
Sonic Healthcare (SKHHY) Australia $8.244B 0.00
Amplifon S.p.A (AMFPF) Italy $6.136B 31.28
Bausch + Lomb (BLCO) Canada $6.118B 28.46
Organon (OGN) United States $4.054B 4.09
Sotera Health (SHC) United States $3.676B 19.67
BrightSpring Health Services (BTSG) United States $3.230B 68.70
Alignment Healthcare (ALHC) United States $2.795B 0.00
Concentras Parent (CON) United States $2.691B 0.00
Surgery Partners (SGRY) United States $2.566B 29.26
Premier (PINC) United States $2.156B 11.22
PACS (PACS) United States $2.106B 0.00
Ardent Health Partners (ARDT) United States $2.013B 0.00
GeneDx Holdings (WGS) United States $1.909B 0.00
Progyny (PGNY) United States $1.788B 36.21
GoodRx Holdings (GDRX) United States $1.742B 45.70
Ryman Healthcare (RYHTY) New Zealand $1.658B 0.00
Teladoc Health (TDOC) United States $1.565B 0.00
Agilon Health (AGL) United States $1.273B 0.00
Pediatrix Medical (MD) United States $1.189B 11.63
CareDx (CDNA) United States $1.150B 0.00
Embecta (EMBC) United States $1.086B 7.59
AMN Healthcare Services Inc (AMN) United States $0.986B 6.67
Establishment Labs Holdings (ESTA) $0.968B 0.00
Auna S.A (AUNA) Luxembourg $0.624B 0.00
SBC Medicals (SBC) United States $0.518B 0.00
InnovAge Holding (INNV) United States $0.484B 0.00
Sonida Senior Living (SNDA) United States $0.429B 0.00
QDM (QDMI) Hong Kong, SAR China $0.426B 11.15
DocGo (DCGO) United States $0.426B 16.04
Enhabit (EHAB) United States $0.402B 34.74
MultiPlan (MPLN) United States $0.260B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.239B 0.00
Sera Prognostics (SERA) United States $0.217B 0.00
Beauty Health (SKIN) United States $0.216B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Nutex Health (NUTX) United States $0.206B 0.00
Performant Healthcare (PHLT) United States $0.181B 0.00
Biodesix (BDSX) United States $0.167B 0.00
So-Young (SY) China $0.110B 18.60
ModivCare (MODV) United States $0.093B 5.03
Ascend Wellness Holdings (AAWH) United States $0.085B 0.00
IceCure Medical (ICCM) Israel $0.068B 0.00
NeueHealth (NEUE) United States $0.062B 1.63
Singular Genomics Systems (OMIC) United States $0.050B 0.00
Oncology Institute (TOI) United States $0.042B 0.00
OncoCyte (OCX) United States $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.032B 0.00
Co-Diagnostics (CODX) United States $0.025B 0.00
Pheton Holdings (PTHL) China $0.025B 0.00
KindlyMD (KDLY) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
NewGenIvf Group (NIVF) Thailand $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
Aclarion (ACON) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00